Key statistics
On Thursday, Lifecore Biomedical Inc (LFCR:NSQ) closed at 5.68, 54.38% above the 52 week low of 3.68 set on Aug 29, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.93 |
---|---|
High | 5.93 |
Low | 5.56 |
Bid | 5.41 |
Offer | 6.10 |
Previous close | 5.93 |
Average volume | 130.56k |
---|---|
Shares outstanding | 36.83m |
Free float | 34.91m |
P/E (TTM) | 160.40 |
Market cap | 218.20m USD |
EPS (TTM) | 0.0369 USD |
Data delayed at least 15 minutes, as of Oct 31 2024 20:00 BST.
More ▼
- Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update
- Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock
- Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024
- Lifecore Biomedical Selected by Lindy Biosciences to Support Process Development and Commercial Scale-Up for Innovative Microglassification Formulation Technology
- Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events
- Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational
- Lifecore Biomedical to Participate in Craig-Hallum Bioprocessing Conference
- Lifecore Biomedical Regains Compliance with Nasdaq Listing Requirements
- Lifecore Biomedical Appoints Brikkelle Thompson as Senior Vice President of Human Resources
- Lifecore Biomedical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
More ▼